PHARMACEUTICAL giant Eli Lilly has plans to build a 22,000sq m facility at its Co Cork plant.
The group has lodged an application for planning permission for a building at its site at Dunderrow, Kinsale, for the potential manufacture of biopharmaceuticals at the plant.
The application, which has been lodged with Cork County Council, is for a three-storey, 22,680sq m building.
Biopharmaceuticals are medicines created using biotechnology.
Eli Lilly has invested significantly in biotechnology development and the Dunderrow site is one of the primary manufacturing sites for such new products.
The planning application for a the facility is in anticipation of a future increase in demand for the group’s biopharmaceutical products.
A company spokesman said the company’s goal was to be ready for every eventuality, should it be successful in securing product lines for manufacture at the west Cork plant.
The Co Cork plant, which manufactures the active ingredients for a number of pharmaceutical products, including drugs to treat diabetes, schizophrenia and depression, is one of six Eli Lilly bulk manufacturing factories worldwide.